NCT06142838

Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,600 (estimated)
• Sponsor: University Ghent · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to evaluate a community pharmacist intervention aimed at improving medication adherence in patients starting newly prescribed medication for cardiovascular disease prevention. The main questions it aims to answer are: * Does this community pharmacist intervention improve medication adherence? * Which patients benefit the most from the intervention? * How do patients experience the start-up of newly prescribed medication (which questions do they have and do they experience side effects?)? * How do patients and pharmacists experience the intervention?

Conditions

• Cardiovascular Diseases
• Cardiovascular Disease Prevention

Interventions

Type	Name	Description
BEHAVIORAL	community pharmacist intervention	The community pharmacist intervention comprises 2 parts: (1) first prescription counseling (oral and written information), and (2) a follow-up consultation (by telephone or in person) 7-14 days later, to identify problems with adherence/treatment

Timeline

• Start date: 2023-10-03
• Primary completion: 2024-05-31
• Completion: 2024-08-31
• First posted: 2023-11-22
• Last updated: 2023-11-22

Locations

1 site across 1 country: Belgium